Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages

Prostate cancer (PCa) has become the second leading cause of male cancer-related mortality in the United States. Mesenchymal stem cells (MSCs) are able to migrate to tumor tissues, and are thus considered to be novel antitumor carriers. However, due to their immunosuppressive nature, the application...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yang, Zhang, Qingyun, Meng, Qinggui, Zong, Chen, Liang, Lei, Yang, Xue, Lin, Rui, Liu, Yan, Zhou, Yang, Zhang, Hongxiang, Hou, Xiaojuan, Han, Zhipeng, Cheng, Jiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper: Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342066/
https://www.ncbi.nlm.nih.gov/pubmed/27764779
http://dx.doi.org/10.18632/oncotarget.12737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342066/
https://www.ncbi.nlm.nih.gov/pubmed/27764779
http://dx.doi.org/10.18632/oncotarget.12737

Ejemplares similares